Skip to main content
. 2012 Jun 1;18(6):CR361–CR367. doi: 10.12659/MSM.882879

Figure 1.

Figure 1

Representative immunohistochemical staining patterns of IPO13 in human proliferative phase endometrium, secretory phase endometrium, endometriosis and endometrial carcinoma. (A) IPO13-expressing cells in proliferative phase endometrium; ×400 magnification. (B) IPO13-expressing cells in secretory phase endometrium; ×400 magnification. (C) IPO13-expressing cells in endometriosis; ×200 magnification. (D) IPO13-expressing cells in endometrial carcinoma; ×400 magnification.